Milestone Pharmaceuticals Inc.
MIST
$1.98
-$0.01-0.50%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.65% | -14.71% | 5.74% | 30.44% | 27.82% |
| Total Depreciation and Amortization | 5.89% | 6.07% | 6.09% | 8.03% | 29.45% |
| Total Amortization of Deferred Charges | 15.97% | 16.96% | 16.31% | 51.64% | 123.13% |
| Total Other Non-Cash Items | -5.00% | -19.63% | -29.08% | -28.43% | -22.80% |
| Change in Net Operating Assets | 270.79% | 958.30% | 485.76% | 194.13% | 188.38% |
| Cash from Operations | -35.56% | -9.30% | 18.30% | 37.86% | 35.74% |
| Capital Expenditure | 2.38% | 23.21% | 51.25% | 70.54% | 78.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 946.79% | 573.39% | 232.17% | 70.83% | 110.36% |
| Cash from Investing | 961.98% | 571.30% | 231.89% | 74.16% | 110.12% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 67.85% | -99.02% | -99.15% | 4,668.56% | 3,331.93% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -44.27% | -100.00% | -102.51% | 265.48% | 265.48% |
| Cash from Financing | 53.03% | -99.15% | -100.20% | -32.79% | -33.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,060.48% | 251.26% | 154.77% | 88.67% | 110.65% |